Within the realm of ophthalmology, ocular tumors pose a distinctive challenge. These growths, while infrequent, can originate from diverse eye structures, such as the iris, retina, choroid, or optic nerve. Whether benign or malignant, they carry the potential for vision impairment or even necessitate eye removal if untreated. Diagnosis typically entails a comprehensive eye exam, alongside imaging techniques like ultrasound or MRI, sometimes followed by biopsy for confirmation. Treatment strategies vary based on factors like tumor type, size, and location, encompassing observation, surgical intervention, radiation therapy, or chemotherapy. Effective management demands seamless collaboration among ophthalmologists, oncologists, and other specialists to safeguard both vision and ocular health. Timely detection and intervention stand as linchpins in optimizing outcomes for individuals contending with ocular tumors.
Choroidal osteomas are rare benign ossifying tumours with predominantly a female preponderance. They present as elevated, irregular yellow-white, irregular and well-defined lesions most commonly in a…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Ocular Tumors work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Ocular Tumors research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Ocular Tumors track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Tumors are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Ocular Tumors track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
